424 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B N/A
Article Searches
Segerstrom Center for the Arts announces its free Summer Jazz Series https://www.ocregister.com/2019/05/23/segerstrom-center-for-the-arts-announces-its-free-summer-jazz-series/ May 23, 2019 - Segerstrom Center for the Arts in Costa Mesa has announced its 2nd Annual Summer Jazz Series of free concerts, which will be held in its outdoor Julianne and George Argyros Plaza. Every Friday night June 7-Aug. 30 from 7-9 p.m., guests can show up for a free evening of a variety of styles of jazz […]
JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/416789/jazz-vs-pcrx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-416789 May 20, 2019 - JAZZ vs. PCRX: Which Stock Is the Better Value Option?
Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? http://www.zacks.com/stock/news/415565/is-jazz-pharmaceuticals-jazz-stock-undervalued-right-now?cid=CS-ZC-FT-415565 May 17, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jazz Pharmaceuticals (JAZZ) Investor Presentation - Slideshow https://seekingalpha.com/article/4262638-jazz-pharmaceuticals-jazz-investor-presentation-slideshow?source=feed_sector_healthcare May 10, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with this event.
3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates http://www.zacks.com/stock/news/412663/3-small-drug-stocks-poised-to-beat-q1-earnings-estimates?cid=CS-ZC-FT-412663 May 10, 2019 - So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.
3 Reasons Why Growth Investors Shouldn't Overlook Jazz (JAZZ) http://www.zacks.com/stock/news/412509/3-reasons-why-growth-investors-shouldnt-overlook-jazz-jazz?cid=CS-ZC-FT-412509 May 10, 2019 - Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates http://www.zacks.com/stock/news/410916/jazz-pharma-jazz-q1-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-410916 May 08, 2019 - Jazz Pharmaceuticals (JAZZ) reports encouraging first-quarter 2019 earnings and revenues and maintains its guidance for 2019.
Jazz Pharmaceuticals Hits All the Right Notes in Q1 https://www.fool.com/investing/2019/05/08/jazz-pharmaceuticals-hits-all-the-right-notes-in-q.aspx?source=iedfolrf0000001 May 08, 2019 - The drugmaker reported strong revenue and earnings growth thanks largely to solid growth for narcolepsy drug Xyrem.
Jazz Pharmaceuticals (JAZZ) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/08/jazz-pharmaceuticals-jazz-q1-2019-earnings-call-tr.aspx?source=iedfolrf0000001 May 08, 2019 - JAZZ earnings call for the period ending March 31, 2019.
Jazz Pharmaceuticals, Inc. (JAZZ) CEO Bruce Cozadd on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4261308-jazz-pharmaceuticals-inc-jazz-ceo-bruce-cozadd-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 08, 2019 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Q1 2019 Results Earnings Conference Call May 7, 2019, 04:30 PM ET Company Participants Katherine Littrell - Head of Investor Relations Bruce Cozadd - Chairman

Pages: 12345678...43

<<<Page 3>